2. Topical antiseptic products available for treating chronic wounds.
Product and formulations | Formulations | Bacterial spectrum | Advantages | Disadvantages | Costa | Indicationsb and comments |
Acetic acid | 0.25%, 0.5%, and 1% solutions | Bactericidal against most gram‐positive and gram‐negative organisms, including Pseudomonas aeruginosa | Inexpensive; shown to eliminate P aeruginosa colonisation from burn | Cytotoxic in vitro although maybe not in vivo; limited activity against biofilm | $ | No longer as widely used as in the past |
Cadexomer iodine | Gel,c ointment, and dressing | Polysaccharide starch lattice; active agent is slowly released free iodine; broad spectrum of activity (same as iodine) | Reduced local toxicity compared to iodine; elemental iodine released on exposure to exudate | Application may cause stinging and erythema, but less tissue damage than other iodine products; effect may not persist, and efficacy may be reduced in body fluids. | $$ | Indicated for use in cleaning wet ulcers and wounds and reducing microbial load in the wound environment |
Cetrimide | Solution, 40% | Active against bacteria and fungi; not active against P aeruginosa | May be less toxic to wound tissues than other antiseptics | May be corrosive and is potentially harmful if swallowed | $ | Not available in the USA |
Chlorhexidine gluconate |
Solution, 2% and 4%; liquid, 2% and 4%; hand rinse, 0.5%; wipes, 0.5%; sponge/brush, 4%; and foam, 4% | Active against gram‐positive bacteria (e.g. Staphylococcus aureus) and gram‐negative bacteria, including P aeruginosa | Persistent activity up to 6 h after application; few adverse effects | Hypersensitivity, including anaphylaxis, generalised urticaria, bronchospasm, cough, dyspnoea, wheezing, and malaise; may cause serious injury to the eye and middle ear; avoid contact with face or head; some resistance reported |
$ | 2% chlorhexidine indicated as surgical hand scrub, hand wash, skin and wound cleanser; polyhexanide is a similar, newer biguanide. |
Hexachlorophene | Liquid, 3%; foam, 0.23% with 56% alcohol | Biguanide that is bacteriostatic against Staphylococcus species and other gram‐positive bacteria | May retain residual effect on skin for several days | Rapidly absorbed and may result in toxic blood levels; application to burns has resulted in neurotoxicity and death; may cause central nervous system stimulation and convulsions, dermatitis, and photosensitivity reactions | $$$ | Not recommended for routine use on wounds due to potential toxicity |
Iodine compounds and iodine tincturec | Solution (aqueous) 2% and 2.4%; and tincture (44% to 50% alcohol) 2% and 2.4% | Microbicidal against bacteria, fungi, viruses, spores, protozoa, and yeasts | Broad spectrum | Highly toxic if ingested or significantly absorbed; do not use with occlusive dressings; causes pain and stains skin and clothing; use cautiously in people with thyroid disorders | $ | Iodine compounds are now rarely used for wound management; cadexomer iodine and povidone iodine products are less toxic. |
Povidone iodinec | Ointment, 1%, 4.7%, 10%; solution, 1% and 10%; also wash, scrub, cleanser, gel, aerosol, gauze pad, swab, and other forms | Broad spectrum includes S aureus and enterococci; active ingredient is liberated free iodine; shares spectrum but is less potent than iodine | Less irritating to skin and allergenic than iodine. Can be covered with dressings. Clinically significant resistance very rare | Antibacterial action requires at least 2 min contact; may cause stinging and erythema; effect may not persist, and efficacy may be reduced in body fluids; prolonged use may cause metabolic acidosis; stains skin and clothing; possible interaction with starches in dressings | $ | Indicated for perioperative skin cleansing and for cleansing and prevention of infection in superficial burns, incisions, and other superficial wounds |
Sodium hypochlorite (Dakin’s solution and EUSOL) |
Solution, 0.0125%, 0.125%, 0.25%, and 0.5% | Vegetative bacteria, viruses, and some spores and fungi | Inexpensive | No known systemic toxicity. May require prolonged contact for antibacterial action; inactivated by pus; toxic to fibroblasts and keratinocytes, and may cause pain or lyse blood clots | $ | A concentration of 0.025% is both bactericidal and non‐toxic to tissues (Heggers 1991). |
Hydrogen peroxidec | Solution, 1% and 3%; and cream, 1% | Oxidizing agent active against many gram‐positive and gram‐negative bacteria | Broad‐spectrum, bactericidal, inexpensive; no known 1q11 | May cause some discomfort | $ | Commonly used, but few clinical studies |
Silver nitrate | Solution 0.5%, 10%, 25%, and 50%; ointment, 10%; and swabs, 25% to 50% | Silver ions are bactericidal against a broad spectrum of gram‐positive and gram‐negative bacteria. | Low cost; easily applied | Painful on application; stains tissues; may delay healing; concentrations 10.5% cause cauterisation; inactivated by wound exudates and chlorine | $ | Previously widely used, but now largely replaced by other compounds, including newer silver dressings |
Silver dressings | At least 6 approved products with different properties | Slowly released silver ions have broad spectrum, including MRSA and VRE. | Provide sustained levels of active silver ions; microbial resistance is rare; less painful and few adverse effects than silver nitrate; variety of products adaptable to different types of wounds; infrequent application required | Levels of silver ions at wound interface not well defined; may cause silver staining of tissues; may delay epithelialisation; relatively expensive; few published comparative trials | $$ | Should not substitute for non‐medicated dressings for uninfected wounds; may be useful for subclinically infected, highly colonised wounds or for wounds being prepared for skin grafting |
Abbreviations: EUSOL, Edinburgh University Solution of Lime; MRSA, methicillin‐resistant Staphylococcus aureus; VRE, vancomycin‐resistant enterococci.
aCosts are approximate in USD per day for treating 100‐square centimetre wound, as follows: $, < USD 3; $$, USD 3 to 15; and $$$, > USD 15. bUS Food and Drug Administration–approved indications. cAvailable without prescription. Modified from Lipsky 2009.